Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
90
16
22
32
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
20.0%
18 terminated/withdrawn out of 90 trials
64.0%
-22.6% vs industry average
6%
5 trials in Phase 3/4
0%
0 of 32 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (90)
Horse-assisted Interventions in an Oncological Centre
Role: lead
Healthcare Providers' Attitudes Toward Oncology Patients With Mental Disorders
Role: collaborator
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
Role: lead
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
Role: lead
MelaMEd Online Training for General Practitioners to Improve Melanoma Detection and Management
Role: lead
Validation of a Prognostic Method for Assessing the Risk of Distant Metastasis in Early-stage Breast Cancer
Role: collaborator
Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma
Role: lead
Radiometabolic Therapy With 177Lu PSMA in PSMA PET/CT Positive Advanced/Metastatic Tumours:
Role: lead
Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in Oncohematology
Role: lead
Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Advanced Oncological, Renal and Pulmonary Diseases
Role: lead
ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate
Role: lead
Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)
Role: lead
Acupuncture And Inflammatory Status In Breast Cancer Patients With Climateric Syndrome.
Role: lead
Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma
Role: lead
Pembrolizumab and Olaparib Treatment of Extensive Small Cell Lung Cancer (ES-SCLC)
Role: lead
Skin Toxicity by Oncological Therapies
Role: lead
Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)
Role: lead
"Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALL
Role: lead
The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA)
Role: lead
Whole Body MRI in Oncology
Role: lead